Paid Clinical Trials Idaho Falls

Discover 58 paid clinical trials in Idaho Falls, Idaho. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 58

Investigational CMV Vaccine Study for Volunteers Ages 9–15Investigational CMV Vaccine Study for Volunteers Ages 9–15

PHASE1

PHASE2

Sponsor:

Moderna

Location:

Idaho Falls ID, Salt Lake City UT, Spokane WA, Fort Collins COshow 43 more

Code:

NCT05575492

Conditions

Cytomegalovirus

Eligibility Criteria

Sex: All

Age: 9 - 15

Healthy Volunteers: Accepted

Interventions

mRNA-1647

Placebo

Desara ® One Single Incision Sling 522 StudyDesara ® One Single Incision Sling 522 Study

Recruiting

Sponsor:

Caldera Medical, Inc.

Location:

Idaho Falls ID, Las Vegas NV, Seattle WA, Albuquerque NMshow 11 more

Code:

NCT04772131

Conditions

Stress Urinary Incontinence

Eligibility Criteria

Sex: Female

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Desara® One Single Incision Sling

Desara® Blue Transobturator Sling

Continuous Monitoring and Control of HypoglycemiaContinuous Monitoring and Control of Hypoglycemia

Recruiting

Sponsor:

DexCom, Inc.

Location:

Idaho Falls ID, Ogden UT, Sacramento CA, San Mateo CAshow 20 more

Code:

NCT03340831

Conditions

Diabetes

Eligibility Criteria

Sex: All

Age: 2+

Healthy Volunteers: Not accepted

Interventions

Continuous Glucose Monitoring (CGM)

The Clostridioides Difficile Trial of REC-3964The Clostridioides Difficile Trial of REC-3964

Recruiting

PHASE2

Sponsor:

Recursion Pharmaceuticals Inc.

Location:

Idaho Falls ID, Salt Lake City UT, Sacramento CA, Madison WIshow 6 more

Code:

NCT06536465

Conditions

Recurrent Clostridioides Difficile Infection

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

REC-3964

A 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With MigraineA 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine

Recruiting

PHASE3

Sponsor:

Eli Lilly and Company

Location:

Ammon ID, Logan UT, Meridian ID, Aurora COshow 73 more

Code:

NCT04396574

Conditions

Migraine

Eligibility Criteria

Sex: All

Age: 6 - 17

Healthy Volunteers: Not accepted

Interventions

Lasmiditan

LMN-201 for Prevention of C. Difficile Infection RecurrenceLMN-201 for Prevention of C. Difficile Infection Recurrence

Recruiting

PHASE2

PHASE3

Sponsor:

Lumen Bioscience, Inc.

Location:

Idaho Falls ID, Butte MT, Los Angeles CA, Omaha NEshow 13 more

Code:

NCT05330182

Conditions

Clostridioides Difficile Infection

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

LMN-201

Placebo

A Study of Galcanezumab (LY2951742) in Participants 12 to 17 Years of Age With Chronic MigraineA Study of Galcanezumab (LY2951742) in Participants 12 to 17 Years of Age With Chronic Migraine

Recruiting

PHASE3

Sponsor:

Eli Lilly and Company

Location:

Ammon ID, Logan UT, Boise ID, Meridian IDshow 41 more

Code:

NCT04616326

Conditions

Chronic Migraine

Eligibility Criteria

Sex: All

Age: 12 - 17

Healthy Volunteers: Not accepted

Interventions

Galcanezumab

Placebo

A Study of TAK-279 in Participants With Moderate-to-Severe Plaque PsoriasisA Study of TAK-279 in Participants With Moderate-to-Severe Plaque Psoriasis

Recruiting

PHASE3

Sponsor:

Takeda

Location:

Idaho Falls ID, Calgary, Henderson NV, Portland ORshow 85 more

Code:

NCT06550076

Conditions

Plaque Psoriasis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

TAK-279

MILD® Percutaneous Image-Guided Lumbar Decompression: a Medicare Claims StudyMILD® Percutaneous Image-Guided Lumbar Decompression: a Medicare Claims Study

Recruiting

Sponsor:

Vertos Medical, Inc.

Location:

Idaho Falls ID, Blackfoot ID, Boise ID, Meridian IDshow 1071 more

Code:

NCT03072927

Conditions

Lumbar Spinal Stenosis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

MILD

Interspinous Process Decompression

Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules/Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe PainStudy Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules/Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain

Recruiting

PHASE3

Sponsor:

AbbVie

Location:

Idaho Falls ID, Salt Lake City UT, Draper UT, Pleasant Grove UTshow 133 more

Code:

NCT04333576

Conditions

Endometriosis

Eligibility Criteria

Sex: Female

Age: 18 - 49

Healthy Volunteers: Not accepted

Interventions

Elagolix

Placebo

Combined Oral Contraceptive

A Study of Galcanezumab (LY2951742) in Participants 6 to 17 Years of Age With Episodic MigraineA Study of Galcanezumab (LY2951742) in Participants 6 to 17 Years of Age With Episodic Migraine

Recruiting

PHASE3

Sponsor:

Eli Lilly and Company

Location:

Ammon ID, Blackfoot ID, Boise ID, Meridian IDshow 38 more

Code:

NCT03432286

Conditions

Episodic Migraine

Eligibility Criteria

Sex: All

Age: 6 - 17

Healthy Volunteers: Not accepted

Interventions

Galcanezumab

Placebo